RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

Ahern, E; Harjunpaa, H; O'Donnell, JS; Allen, S; Dougall, WC; Teng, MWL; Smyth, MJ

Teng, MWL (reprint author), QIMR Berghofer Med Res Inst, Canc Immunoregulat & Immunotherapy Lab, 300 Herston Rd, Herston, Qld 4006, Australia.; Smyth, MJ (reprint author), QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, 300 Herston Rd, Herston, Ql

ONCOIMMUNOLOGY, 2018; 7 (6):

Abstract

Receptor activator of NF-kappa B ligand (RANKL) and its receptor RANK, are members of the tumor necrosis factor and receptor superfamilies, respective......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索